Document and Entity information
Document and Entity information | Nov. 14, 2023 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | Nov. 14, 2023 |
Entity File Number | 001-40237 |
Entity Registrant Name | Gain Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 85-1726310 |
Entity Address, Address Line One | 4800 Montgomery Lane |
Entity Address, Adress Line Two | Suite 220 |
Entity Address, City or Town | Bethesda |
Entity Address, State or Province | MD |
Entity Address, Postal Zip Code | 20814 |
City Area Code | 301 |
Local Phone Number | 500-1556 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 par value |
Trading Symbol | GANX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001819411 |
Amendment Flag | false |